Bvf Inc Ironwood Pharmaceuticals Inc Transaction History

Bvf Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$14.31 - $17.65 $8.68 Million - $10.7 Million	-606,715 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$11.83 - $16.2 $58.4 Million - $80 Million	-4,935,685 Reduced 89.05%	606,715 $11.6 Million
Q1 2018 May 07, 2018	BUY	$11.13 - $13.63 $61.7 Million - $75.5 Million	5,542,400 New	5,542,400 $85.5 Million
Q4 2017 Feb 14, 2018	SELL	$12.16 - $14.58 $34.3 Million - $41.1 Million	-2,820,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.07 - $14.87 $34 Million - $41.9 Million	2,820,000	2,820,000 $44.5 Million

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $562M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.